TRENDING TOPICS
Who's Blogging
- Christopher Little
- Earl Perkins
- Laurel Erickson
- Debbie Wilson
- Anton Chuvakin
- Marc Brown
- Ted Chamberlin
- Andrew White
- Sally Witzky
- Hank Barnes
- Rene Buest
- John Wheeler
- Stephen White
- Chris Ross
- Jonathan Care
- Mark Raskino
- Cindi Howson
- Augie Ray
- Michele Buckley
- Charles Golvin
- Sid Deshpande
- Augusto Barros
- Svetlana Sicular
- Martina Kurth
- Benjamin Bloom
- Christy Ferguson
- Craig Roth
- Avivah Litan
- Paul Rabinovich
- Jim Hare
- Homan Farahmand
- Ian Mcshane
- Pete Basiliere
- Arthur Villa
- Werner Goertz
- Bryan Yeager
- Manjunath Bhat
- Frank Buytendijk
- Deacon Wan
- James Meyers
- Erik Heidt
- John Kostoulas
- Anna Maria
- Robert Hetu
- Tom Murphy
- Nick Heudecker
- Simon Walker
- Marco Meinardi
- Jay Wilson
- Jeff Chamberlain
A CIO’s 24 Hours of Le Mans
by Michael Shanler | June 28, 2017
CIOs are competing in an endurance race. Winning requires carefully orchestrated activities that rely on technology, team work, precision driving, and a bit of luck. As in racing, the victorious...
Hype Cycle for Life Science R&D
by Michael Shanler | July 25, 2016
This year, we unveiled a brand new hype cycle, one that is 100% Life Science R&D-focused.
“… the moon does not present the same face every day. It waxes, or grows larger, until...
Mutate the DNA of Pharma Externalization
by Michael Shanler | May 12, 2016
Here’s a prediction. Life Science CxOs that continue to oversimplify “externalized innovation” strategies are in for a career-ending surprise in a few years. For details, check this out: Industry...
R&D Cool Vendor Landscaping
by Michael Shanler | May 1, 2016
A few days ago, we released the R&D Cool Vendors list. Similar to selecting the right plants for our yard, filtering the right technology-based vendors for this report required a...
“Accelerating R&D” Key Initiatives for Life Science Manufacturers 2016
by Michael Shanler | January 27, 2016
Before each calendar year begins, we put a lot of effort into outlining areas of research and how these areas align with strategic key initiatives (KIs). The life science-related KIs...
Cool Vendors in Life Science
by Michael Shanler | April 24, 2015
Last week, Stephen Davies and I published the Cool Vendors report for Life Science. The vendors mentioned are all relative new comers (either by incorporation date, or they have recently...
Gartner 2015 Life Sciences Agenda Has Published
by Michael Shanler | February 15, 2015
Last year, having spent an exceptional amount of quality time with clients, at conferences, and doing research, caused me to reflect on my teenage conversations with my grandparents. Older, wiser...
Life Science Track at Orlando ITxpo 2014 Symposium
by Michael Shanler | September 12, 2014
This year, Gartner has organized a specific Life Science IT track on "Industry Sunday." This is a great opportunity for IT and CxO business leaders to have dialog about the...
2014 Life Science Hype Cycle has published
by Michael Shanler | August 5, 2014
Fifty technologies are profiled by Gartner analysts in this year's Hype Cycle for Life Sciences, 2014. This is the most densely packed hype cycle since the LS HC introduction...
Pharma’s Illness Requires Digital Treatment
by Michael Shanler | July 31, 2014
The Pharma industry is sick. The “patent cliff” has taken a serious toll as more drugs go generic. R&D productivity is down as an aggregate across the entire sector. Execs...
